BranchLab Lands $26 Million in Series A
BranchLab, a Boulder, CO-based AI platform for pharma commercialization, has raised $26 million in Series A funding, bringing its total funding to $35 million.
BranchLab, a Boulder, CO-based AI platform for pharma commercialization, has raised $26 million in Series A funding, bringing its total funding to $35 million.
Investors
The round was led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures.
McKesson Ventures is the corporate venture capital arm of McKesson Corporation, one of the largest healthcare services and pharmaceutical distribution companies in the United States. Founded in 2014 and based in San Francisco, McKesson Ventures invests in early- and growth-stage healthcare technology companies focused on improving the efficiency, accessibility, and quality of healthcare delivery. The firm primarily backs startups in digital health, health IT, AI-driven clinical solutions, pharma services, oncology, care navigation, and data infrastructure.
BranchLab Use of Funds
The company will use the funding to expand enterprise deployments, deepen integrations across the healthcare and media ecosystem, and continue developing its unified AI platform for pharma commercialization.
About BranchLab
Founded by Josh Walsh, Michael Parkes, and Chris Cagle, BranchLab is transforming healthcare commercialization with AI-native technology that helps leading healthcare organizations and their agencies connect patients, providers, and caregivers to life-improving therapies and resources. The company enables pharma organizations to identify patient and healthcare professional audiences, optimize activation strategies, and measure outcomes in near real time using privacy-safe AI models. Headquartered in Boulder, Colorado, BranchLab’s mission is to enable better healthcare decisions by applying AI in a way that is privacy-safe, rigorous, and designed for real-world use.
Funding Details
Company: BranchLab
Raised: $26.0M
Round: Series A
Funding Date: May 2026
Lead Investor: McKesson Ventures
Additional Investors: FCA Venture Partners, Sanofi Ventures, AIX Ventures
Company Website: https://branchlab.com/
Software Category: AI Pharmaceutical Commercialization Software
